Clinical Trial Update: Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy [NA]

View source ↗

Summary

A clinical trial evaluating subthreshold nanosecond laser therapy for non-resolving central serous chorioretinopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Snippet

Sponsor: Nova Eye Medical Pty Ltd. | Conditions: Central Serous Chorioretinopathy | NA | Status: RECRUITING